BIOMARIN PHARMACEUTICAL INC (BMRN) /
The profitability of BIOMARIN PHARMACEUTICAL INC over the past 10 years
Chart BIOMARIN PHARMACEUTICAL INC: gross profit, operating income, net income, fiscal 2016–2025 Open the chart →BIOMARIN PHARMACEUTICAL INC reported net income of $348.9M in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $2.5B and operating income of $409.48M. It reported a profit in 5 of the 10 years shown, and a loss in fiscal 2016, 2017, 2018, 2019 and 2021. Its highest net income in these years was $854.03M, in fiscal 2020.
Year by year
| Fiscal year | Gross profit | Operating income | Net income |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $2.5B* | $409.48M | $348.9M |
| 2024ended Dec 31, 2024 | $2.27B* | $484.21M | $426.86M |
| 2023ended Dec 31, 2023 | $1.89B* | $185.77M | $167.65M |
| 2022ended Dec 31, 2022 | $1.59B* | $160.97M | $141.56M |
| 2021ended Dec 31, 2021 | $1.38B* | -$82.34M | -$64.08M |
| 2020ended Dec 31, 2020 | $1.34B* | -$43.44M | $854.03M |
| 2019ended Dec 31, 2019 | $1.34B* | -$100.46M | -$23.85M |
| 2018ended Dec 31, 2018 | $1.18B* | -$123.52M | -$77.21M |
| 2017ended Dec 31, 2017 | $1.07B* | -$14.7M | -$117.04M |
| 2016ended Dec 31, 2016 | $907.23M* | -$803.43M | -$630.21M |
Fiscal years as BIOMARIN PHARMACEUTICAL INC reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on BIOMARIN PHARMACEUTICAL INC
- The revenue of BIOMARIN PHARMACEUTICAL INC
- The cash flow of BIOMARIN PHARMACEUTICAL INC
- The debt of BIOMARIN PHARMACEUTICAL INC
- All of BIOMARIN PHARMACEUTICAL INC's financials, charted
Companies of a similar size
Not investment advice. This page shows what BIOMARIN PHARMACEUTICAL INC filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.